288 related articles for article (PubMed ID: 20547755)
1. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.
Van Rechem C; Boulay G; Pinte S; Stankovic-Valentin N; Guérardel C; Leprince D
Mol Cell Biol; 2010 Aug; 30(16):4045-59. PubMed ID: 20547755
[TBL] [Abstract][Full Text] [Related]
2. DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.
Dehennaut V; Loison I; Dubuissez M; Nassour J; Abbadie C; Leprince D
J Biol Chem; 2013 Apr; 288(15):10254-64. PubMed ID: 23417673
[TBL] [Abstract][Full Text] [Related]
3. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
[TBL] [Abstract][Full Text] [Related]
4. HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).
Paget S; Dubuissez M; Dehennaut V; Nassour J; Harmon BT; Spruyt N; Loison I; Abbadie C; Rood BR; Leprince D
Oncotarget; 2017 Jan; 8(2):2916-2935. PubMed ID: 27935866
[TBL] [Abstract][Full Text] [Related]
5. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).
Van Rechem C; Rood BR; Touka M; Pinte S; Jenal M; Guérardel C; Ramsey K; Monté D; Bégue A; Tschan MP; Stephan DA; Leprince D
J Biol Chem; 2009 Jul; 284(31):20927-35. PubMed ID: 19525223
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.
Boulay G; Dubuissez M; Van Rechem C; Forget A; Helin K; Ayrault O; Leprince D
J Biol Chem; 2012 Mar; 287(13):10509-10524. PubMed ID: 22315224
[TBL] [Abstract][Full Text] [Related]
7. Molecular dissection of the interaction between HIC1 and SIRT1.
Dehennaut V; Loison I; Pinte S; Leprince D
Biochem Biophys Res Commun; 2012 May; 421(2):384-8. PubMed ID: 22510409
[TBL] [Abstract][Full Text] [Related]
8. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.
Deltour S; Pinte S; Guerardel C; Wasylyk B; Leprince D
Mol Cell Biol; 2002 Jul; 22(13):4890-901. PubMed ID: 12052894
[TBL] [Abstract][Full Text] [Related]
9. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex.
Zhang Q; Wang SY; Fleuriel C; Leprince D; Rocheleau JV; Piston DW; Goodman RH
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):829-33. PubMed ID: 17213307
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
11. The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).
Foveau B; Boulay G; Pinte S; Van Rechem C; Rood BR; Leprince D
J Biol Chem; 2012 Feb; 287(8):5366-78. PubMed ID: 22184117
[TBL] [Abstract][Full Text] [Related]
12. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes.
Nair SS; Li DQ; Kumar R
Mol Cell; 2013 Feb; 49(4):704-18. PubMed ID: 23352453
[TBL] [Abstract][Full Text] [Related]
13. A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.
Pagan JK; Arnold J; Hanchard KJ; Kumar R; Bruno T; Jones MJ; Richard DJ; Forrest A; Spurdle A; Verdin E; Crossley M; Fanciulli M; Chenevix-Trench G; Young DB; Khanna KK
J Biol Chem; 2007 May; 282(20):15248-57. PubMed ID: 17379597
[TBL] [Abstract][Full Text] [Related]
14. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway.
Li DQ; Pakala SB; Reddy SDN; Ohshiro K; Peng SH; Lian Y; Fu SW; Kumar R
J Biol Chem; 2010 Mar; 285(13):10044-10052. PubMed ID: 20071335
[TBL] [Abstract][Full Text] [Related]
15. HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells.
Fang M; Fan Z; Tian W; Zhao Y; Li P; Xu H; Zhou B; Zhang L; Wu X; Xu Y
Biochim Biophys Acta; 2016 Feb; 1859(2):294-305. PubMed ID: 26619800
[TBL] [Abstract][Full Text] [Related]
16. HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A.
Van Rechem C; Boulay G; Leprince D
Biochem Biophys Res Commun; 2009 Aug; 385(4):586-90. PubMed ID: 19486893
[TBL] [Abstract][Full Text] [Related]
17. SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex.
Gong Z; Brackertz M; Renkawitz R
Mol Cell Biol; 2006 Jun; 26(12):4519-28. PubMed ID: 16738318
[TBL] [Abstract][Full Text] [Related]
18. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.
Srinivasan R; Mager GM; Ward RM; Mayer J; Svaren J
J Biol Chem; 2006 Jun; 281(22):15129-37. PubMed ID: 16574654
[TBL] [Abstract][Full Text] [Related]
19. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation.
Evans PM; Zhang W; Chen X; Yang J; Bhakat KK; Liu C
J Biol Chem; 2007 Nov; 282(47):33994-4002. PubMed ID: 17908689
[TBL] [Abstract][Full Text] [Related]
20. PWWP2A binds distinct chromatin moieties and interacts with an MTA1-specific core NuRD complex.
Link S; Spitzer RMM; Sana M; Torrado M; Völker-Albert MC; Keilhauer EC; Burgold T; Pünzeler S; Low JKK; Lindström I; Nist A; Regnard C; Stiewe T; Hendrich B; Imhof A; Mann M; Mackay JP; Bartkuhn M; Hake SB
Nat Commun; 2018 Oct; 9(1):4300. PubMed ID: 30327463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
